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Design, synthesis and molecular modeling study of substituted 
indoline-2-ones and spiro[indole-heterocycles] with potential 
activity against Gram-positive bacteria
Longstanding and firsthand infectious diseases are chal-
lenging community health threats. A new series of isatin 
derivatives bearing β-hydroxy ketone, chalcone, or spiro-
heterocycle moiety, was synthesized in a good yield. 
Chemical structures of the synthesized compounds were 
elucidated using spectroscopic techniques and elemental 
analysis. Antibacterial activities of the compounds were 
then evaluated in vitro and by in silico modeling. The com-
pounds were more active against Gram-positive bacteria, 
Staphylococcus aureus (MIC = 0.026–0.226 mmol L–1) and 
 Bacillus subtilis (MIC = 0.348–1.723 mmol L–1) than against 
Gram-negative bacteria (MIC = 0.817–7.393 mmol L–1). Only 
3-hydroxy-3-(2-(2,5-dimethylthiophen-3-yl)-2-oxoethyl)in-
dolin-2-one (1b) was found as active as imipenem against 
S. aureus (MIC = 0.026 mmol L–1). In silico docking of the 
compounds in the binding sites of a homology modeled 
structure of S. aureus histidine kinase-Walk allowed us to 
shed light on the binding mode of these novel inhibitors. 
The highest antibacterial activity of 1b is consistent with 
its highest docking score values against S. aureus histidine 
 kinase.
Keywords: 2-indolinone, spiro[indole-heterocyles], anti-
microbial, docking study
Pathogenic infectious diseases pose a serious health problem. The mortality rate asso-
ciated with infectious diseases is rapidly increasing due to a rapid increase in resistance of 
pathogenic strains (bacteria and fungi) against antimicrobials. This is prompting the 
search for novel antimicrobial agents to treat new infectious diseases and/or combat exist-
ing resistant microbes. Indole scaffold represents an interesting class of biologically active 
heterocyclic compounds. The scaffold possesses diverse biological activities including 
anti-inflammatory (1), anticonvulsant (2), antidepressant (3), antiallergic (4), antitubercular 
(5), antidiabetic (6), antiviral (7) and antimicrobial activity (8–11). Oxindole and other re-
lated ring systems also exhibit several biological activities (12–15). Thiosemicarbazone 
AWWAD ABDOH RADWAN1,2,* 
FARES KAED AANAZI1,3 
MOHAMMED AL-AGAMY3,4 
GAMAL MOHAMMAD MAHROUS3
1 Kayyali Chair, College of Pharmacy 
King Saud University 
P.O. Box 2457, Riyadh, 11451 
Saudi Arabia
2 Department of Pharmaceutical Organic 
Chemistry, Faculty of Pharmacy 
Assiut University, Assiut-71527, Egypt
3 Department of Pharmaceutics, College 
of Pharmacy, King Saud University 
Riyadh, Saudi Arabia
4 Department of Microbiology and 
Immunology, Faculty of Pharmacy 
Al-Azhar University, Cairo, Egypt
Accepted January 17, 2021 
Published online February 12, 2021
* Correspondence; e-mail: aradwan@ksu.edu.sa
80
A. A. Radwan et al.: Design, synthesis and molecular modeling study of substituted indoline-2-ones and spiro[indole-heterocycles] with 
potential activity against Gram-positive bacteria, Acta Pharm. 72 (2022) 79–95.
 
 derivatives of indoline-2,3-dione show appreciable antifungal, antibacterial and antiviral 
activities in vivo and in vitro (16). New 1,3-dihydro-3-hydroxy-2H-indol-2-ones exhibit 
promising antibacterial and antifungal activities (17, 18). Benzylideneindolone derivatives 
have potent antimicrobial activity against Staphylococcus aureus at μmol L–1 concentrations 
(19).
Furthermore, 1H-indole-4,7-diones are potent inhibitors of Candida krusei, Cryptococcus 
neoformans and Aspergillus niger (20). Indirubin (Fig. 1) is prepared from natural plants (21) 
and is used in traditional Chinese medicine for the treatment of bacterial and viral infec-
tions (22). Further, convolutamydines are representatives of bioactive 3-substituted-3-hy-
droxy-2-oxindole natural products (Fig. 1) with antioxidant activity (23). In addition, spiro-
indoline-heterocycles have recently attracted much attention as important antimicrobials 
(24–26). Tryptophan-linked indole compound (Fig. 1) inhibits the enzymatic activity of 
histidine kinase (HK) enzyme in an in vitro assay (IC50 = 43.9 mmol L–1); it also inhibits 
methicillin-resistant S. aureus (MRSA) and vancomycin-resistant Enterococcus faecalis (MIC 
= 100 μg mL–1 and 50 μg mL–1, resp.) (27).
Bacteria virulence is an adaptive response to extracellular changes through two-com-
ponent system TCS pathways unique in bacteria (28). The Staphylococcus aureus bacteria 
TCS system comprises HK protein, containing WalK, a membrane-linked sensor protein, 
and a response regulator protein (RR) containing the DNA-binding domain (WalR) (29). 
WalK consists of two domains: one domain is a catalytic or ATP-binding domain and the 
second is a dimerization domain. When HK is activated by external stimuli, ATP binds at 
the catalytic domain of WalK, and the ATP phosphate group is transferred to a conserved 
histidine residue on the dimerization domain. Then, the phosphorylation of RR finally 
results in virulence as one of the bacterial responses to the extracellular stimulus (27). ATP- 
-competitive inhibitors of the microbial HK/WalK are novel antibacterial agents (30, 31). 
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Given these findings and as a continuation of our work aimed to develop new potential 
antimicrobial compounds and other bioactive heterocycles based on the oxindole moiety 
(32–38), we synthesized novel derivatives including spiro[indole-heterocyles] in addition 
to the indolin-2-one scaffold bearing β-hydroxyl ketone group, chalcone moiety or spiro-
hetero cycle fragment. We were focused to generate a new lead structure with enhanced 
anti microbial activity, possibly inhibiting the histidine kinase activities.
EXPERIMENTAL
Chemistry
Electrothermal IA9300 digital melting point apparatus (Cole-Parmer Ltd., UK) was 
used to determine the melting points of compounds in sealed tubes. Thin-layer chroma-
tography was used to assess the purity of the compounds on aluminum TLC plates, silica 
gel coated with fluorescent indicator F254. Perkin Elmer FT-IR system, Spectrum BX (Perkin 
Elmer, USA) spectrophotometer was used to acquire the IR spectra using KBr-pellet 
 technique, in a region of 4000–400 cm−1. Proton and 13C NMR spectra were recorded by 
using a 700 MHz spectrometer (Bruker AscendTM 700, Bruker, USA) in DMSO-d6 as solvent 
and TMS as an internal standard. Chemical shifts are shown in δ ppm. Mass  spectra were 
obtained on Agilent 6410B Triple Quadrupole LC/MS spectrometer (Agilent Technologies, 
USA) using electron spray ionization at ESI 70 eV. Elemental analysis was performed on a 
2400 CHNSO Perkin-Elmer analyzer. Chemicals and reagents, used in the study were 
 purchased from Sigma-Aldrich Chemicals, USA).
Syntheses
General procedure for 3-hydroxy-3-(2-oxo-2-substituted ethyl)-indolin-2-ones (1a,b). – A 
mixture of isatin (1.47 g, 0.01 mol), aryl/heteroaryl methyl ketone (0.01 mol) and diethyl-
amine (1 mL) in ethanol (100 mL) was allowed to stand overnight at room temperature. The 
yellow needles which formed were recrystallized from ethanol.
General procedure for 3-(2-oxo-2-substitutedethylidene)indolin-2-ones (2a-c). – To a mixture 
of 0.01 mol of compound 1a or 1b in 25 mL abs. ethanol, 50 mL of dilute HCl (25 %) was 
added. The reaction mixture was allowed to stand overnight and fine orange needles were 
formed.
General procedure for spiro-indole-2-one-3,5’-(3-(substituted)-2-pyrazolines) (3a-c). – To a 
mixture of 0.01 mol of respective compound 2 and hydrazine hydrate (50 %) in ethanol 
(20 mL), diethylamine (1 mL) was added. The reaction mixture was refluxed for 12–14 
hours. Glacial acetic acid (10 mL) was added to the cold solution and the obtained precipi-
tate was filtered, washed with ethanol and crystallized from glacial acetic acid.
General procedure for spiro-indole-2-one-3,6’-(4-(substituted)-5,6-dihydropyrimidine-2-thi-
ones) (4a-f). – A mixture of a corresponding compound 2 (0.01 mol), thiourea (0.02 mol), 
potassium hydroxide (2 g), abs. ethyl alcohol (60 mL) and water (10 mL) was refluxed for 
10–12 hours. The reaction mixture was concentrated, cooled and the formed precipitate 
was filtered, dried, and purified through recrystallization in absolute ethanol.
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Scheme 1 shows the pathway of the synthesis of the target compounds 1a,b to 4a-f. 
Their physicochemical data are given in Table I and their chemical structures were eluci-
dated through FT-IR, 1H NMR, 13C NMR and mass spectral data and elemental analyses 
(Table II).
In vitro antimicrobial screening
The activity of compounds (1a,b to 4a-f) was evaluated against the Gram-positive 
bacteria S. aureus (ATCC 29213) and B. subtilis (ATCC 10400), Gram-negative bacteria E. coli 
(ATCC 35218) and P. aeruginosa (ATCC 27853) and fungal strain C. albicans (ATCC 2091) 
which were obtained from the American Type Culture Collection (ATCC, Manassas, VA, 
USA). Antimicrobial activity was assessed by serial twofold dilution method. Dimethyl 
sulfoxide (DMSO) was used as a negative control, imipenem was used as a standard drug 
for antibacterial activity testing and fluconazole was used as a standard drug for antifun-
gal activity testing. All compounds were dissolved in DMSO at the concentration of 2048 
μg mL–1. Two-fold dilutions of test and standard compounds were prepared in double 
strength nutrient broth (bacteria) or Sabouraud dextrose broth (fungi). The stock solutions 
were serially diluted to give concentrations between 2048 and 8 μg mL–1 in the respective 
nutrient broth. The tubes were inoculated; inoculum size about 106 colony forming units 
(CFU) mL–1. Then, the tubes were incubated at 37 ± 1 °C for 24 h (bacteria) and at 25 °C for 
7 days (fungi) and were macroscopically examined for turbidity. The culture tubes show-
ing turbidity (lower concentration) and the culture tube showing no turbidity (higher 
concentration) gave the minimum inhibitory concentration (MIC) of the compound.
Scheme 1.
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Molecular modeling
Homology modeling. – The sequence of histidine 
kinase subunit A (Q7A2R7, 471 residues) (39) of S. aureus 
(strain Mu50/ATCC 700699) was used as a query for 
BLAST sequence-database search to identify similar 
X-ray structures (40). The structures were then ranked 
based on similarity percent. The top-ranked PDB 
 entry was selected as a template for the alignment 
with Q7A2R7 and homology model building using 
the Modeller program (41). During modeling, the 
original position of the adenosine-5’-[beta,gamma- 
-methylene]triphosphate (ACP ligand), as the X-ray 
ligand bound to the protein structure of the 5c93.pdb 
in the crystal structure, was retained to rebuild the 
binding cavity. The model of histidine kinase subunit 
A generated by homology modeling was used for the 
preparation of the input receptor files in the Dock6.4 
program (42). The structures of the newly synthesized 
active compounds were used for flexible docking  inside 
the binding site of the model using default dock6 
 parameters and Grid score including van der Waals 
and electrostatic target-ligand interaction of the ligand- 
-binding conformation and the internal energy.
Docking study. – Molecular docking study was 
performed by using the Dock6.4 program on Ubuntu 
14.2 (desktop Linux operating system) supported Dell 
5000 Laptop, Processor, Intel(R) Core(TM) i7-5500U 
CPU @ 2.40GHz and system type 64-bit operating 
 system, x64-based processor. Chemical structures of 
compounds 1a,b to 4a-f were generated in the proto-
nated state under physiological conditions. The model 
of histidine kinase subunit A was used in the docking 
process without further minimization. Using the 
 default settings of the program and defining a sphere of 
10 Å diameter around the center of the binding pocket, 
the co-crystallized ligand was docked in the original 
protein structure. The resulting solutions were clu st-
e red based on the heavy atom root-mean-square 
 deviation (RMSD) values (two superimposed atomic 
coordinates represent two different conformations 
only when RMSD > 1 Å). During docking, all torsion 
angles of the compound were set to free rotation and 
10 binding poses per ligand were obtained. The bind-
ing pose with the highest total score was taken into 
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Scheme 1 shows the synthesis pathway of compounds 1a,b to 4a-f. Compounds 
2,3-hydroxy-3-(2-oxo-2-substituted ethyl)-indolin-2-ones (1a,b) were obtained through the 
condensation of isatin with the appropriate acetophenone in the presence of diethylamine. 
In ethanolic HCl, compounds 1 underwent dehydration resulting in 3-(2-oxo-2-substituted 
ethylidene)indoline-2-ones (2a-c). The reaction of compounds 2a-c with hydrazine hydrate 
led to hydrazone formation with subsequent intra-cyclization through nucleophilic Mi-
chael addition reaction resulting in spiro[indole-pyrazoline] compounds 3a-c. The reaction 
of compounds 2a-c with thiourea resulted in the formation of spiro[indole-dihydropyrim-
idine] compounds 4a-f.
The compounds’ structure was established based on IR, 1H NMR, 13C NMR and mass 
spectral, and elemental analysis data. IR spectra of 1a,b revealed two characteristic bands 
at 1708–1700 cm–1 and 1656–1623 cm–1 (two C=O groups) and one band at 3456–3346 cm–1 
(OH). The latter band disappeared upon conversion of compounds 1a,b into compounds 
2a-c which showed only two characteristic bands at 1707–1700 cm–1 and 1640–1622 cm–1 
(two C=O groups). On the other hand, compounds 3a-c showed characteristic bands at 
1800 cm–1 (one C=O group) while compounds 4a-f showed characteristic bands at 1724–
1695 cm–1 (C=S group) and at 1654–1615 cm–1 (one C=O group).
1H NMR spectra of compounds 1a,b were characterized by the appearance of both OH 
signals at δ 5.83–6.18 ppm and non-equivalent methylene protons signals at δ 3.32-3.73 and 
δ 3.67–4.07 ppm. These signals disappeared, with the concomitant appearance of a singlet 
at δ 8.1–8.34 ppm associated with -CO-CH=C< moiety, in compounds 2a-c confirming their 
formation. 1H NMR spectra of compounds 3a-c and 4a-f were characterized by the appear-
ance of non-equivalent methylene protons signals at δ 3.25–3.79 and δ 3.35–3.83 ppm, and 
at δ 3.37–3.66 and δ 3.64–3.78 ppm, resp. 13C NMR spectra of compounds 1a,b revealed 
characteristic signals at δ 49.8–49.18 ppm (CH2 group), δ 73.59–73.31 ppm (indole-C3) and 
δ 198.11–192.76 ppm (oxoethyl-CO). Compounds 2a-c showed characteristic signals at δ 
146.56–145.45 ppm (indole-C3) and δ 198.11–186.86 ppm (oxoethyl-CO). On the other hand, 
13C NMR spectra of compounds 3a-c showed characteristic signals at δ 46.61–44.25 (pyr-
azoline-C4) and at δ 69.58–56.51 (pyrazoline-C5) while compounds 4a-f showed character-
istic signals at δ 52.44–30.02 ppm (pyrimidinethione-C5) and at δ 55.88–52.43 (pyrimidine-
thione-C6).
Elemental analyses of the synthesized compounds 1a,b–4a-f revealed that the mass 
percentage values found for carbon, hydrogen, nitrogen and sulfur were in accordance 
with the calculated values. The spiro compounds 3a-c and 4a-f showed higher nitrogen 
percentage values (> 11 %) than the compounds 1a,b and 2a-c (nitrogen percentage values 
> 5 %).
Antimicrobial screening
Table III shows the results of antimicrobial screening of compounds 1a,b–4a-f. The 
compounds showed weak antifungal activity, however, marked antibacterial activity was 
obtained. Compounds 1a,b to 4a-f showed promising activity against Gram-positive 
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 bacteria with the higher activity against S. aureus (MIC = 0.026–0.226 mmol L–1) than B. 
subtilis (MIC = 0.348–1.723 mmol L–1) and fair activity against Gram-negative bacteria 
(MIC = 0.817 – 7.393 mmol L–1). As far as S. aureus is concerned compounds 1a,b (MIC = 
0.026–0.047 mmol L–1) are more active than compounds 2a-c (MIC = 0.05–0.226 mmol L–1) 
and 3a-c and 4a-f (MIC 0.044–0.102 mmol L–1).
Acid-catalysed dehydration of β-hydroxy ketone, compound 1a (MIC, S. aureus, 0.047 
mmol L–1) resulted in almost as active chalcone compound 2a (MIC, S. aureus, 0.05 mmol 
L–1). Moreover, β-hydroxy ketone 1b was found equipotent with the reference drug imipe-
nem (MIC, S. aureus, 0.026 mmol L–1), however, transforming it into chalcone type candidate 
produced a nine-fold less potent compound 2c (MIC, S. aureus, 0.226 mmol L–1). Transforma-
tion of the chalcone 2b (MIC, S. aureus 0.107 mmol L–1) into spiro[indole-pyrazoline] led to 
compound 3a with comparable antibacterial activity (MIC, S. aureus 0.102 mmol L–1), how-
ever, its cyclization into spiro[indole-dihydropyrimidinethione] produced compound 4b 
with 2.5-fold enhanced potency (MIC, S. aureus 0.044 mmol L–1). Cyclization of the least 
active compound 2c produced active spiro[indole-pyrazoline] 3b (MIC, S. aureus 0.053 
mmol L–1), and spiro[indole-dihydropyrimidinethione] 4d (MIC, S. aureus 0.046 mmol L–1).
Molecular modeling study
The 3D structure of S. aureus histidine kinase is unavailable. Therefore, to investigate 
the possible interactions between compounds 1a,b to 4a-f and the amino acids that form the 
binding site of S. aureus histidine kinase, homology modeling of the sequence entry Q7A2R7 
with subsequent docking process were performed. Using the BLAST alignment protocol, the 
crystal structure of a monomer histidine kinase domain complex with ACP (5c93.A) of E. coli 
(43), was chosen as a template. The choice was based on BLAST-p alignment and top pair-
wise percentage residue identity (36.53 %) and similarity (38 %). During homology model-
ing, after the heavy atoms have been modeled and all hydrogen atoms added, the protein 
coordinates were minimized using the AMBER94 force field. Briefly, the structure is a com-
pact single domain with 5-stranded β-sheet and 7-α-helices and random coils (Fig. 2). The 
Fig. 2. The backbone structure of S. aureus histidine kinase (Q7A2R7) (homolog model, colored cyan) 
overlayed onto that of 5c93A.pdb (template structure, colored grey).
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RMSD value of the pose from the redocking of the ACP structure itself (0.704 Å) confirmed 
the appropriateness of the docking approach (Fig. 3). The binding site includes a hydropho-
bic pocket delineated with the side-chains of Asp 358, Lys 361, Tyr 362, Asp 386, Ile 399, Arg 
405, Val 406, Gly 416, Asn 417, Gly 418, Leu 419, Gly 420, and Leu 421.
The docking poses of the newly synthesized compounds 1a,b to 4a-f showed hydro-
gen bonding between the C-3 hydroxyl group of the isatin moiety, the C-2 carbonyl oxygen 
of the isatin moiety, the carbonyl oxygen of the acetophenone moiety and the NH group of 
the binding site residues Asn 417, Asn 418 Gly 420, Asn 358, Tyr 360 or Asn 461 (Fig. 4 and 
Table IV). The derived docking scores for compounds 1a,b to 4a-f were in agreement with 
Fig. 3. The co-crystallized ACP (from 5c93.pdb, colored magenta) and the re-docked ACP structure 
(colored forest green), superimposed inside the binding site of homology-modeled Q7A2R7.
Fig. 4. The newly synthesized compounds (colored cyan) overlaid the X-ray ligand ACP (colored  forest 
green) inside the binding site, hydrogen bonds are displayed in orange color).
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the obtained MICs against S. aureus and also with the notion that the antibacterial effects 
of indoline-2-one derivatives might be associated with the inhibition of the histidine 
 kinase-mediated pathway (44). 3-Hydroxy-3-(2-(2,5-dimethylthiophen-3-yl)-2-oxoethyl)
indolin-2-one (compound 1b) was found most active against S. aureus (MIC = 0.026 mmol L–1) 
and also showed the top-score in the docking study (grid score in energy –36.231 kcal mol–1) 
(Tables III and Table IV).
CONCLUSIONS
In summary, a series of new isatin compounds bearing either β-hydroxyketone or 
chalcone moieties were synthesized and biologically evaluated for their antimicrobial 
 activity. The compounds showed promising activity against Gram-positive bacteria with 
the highest specific activity against S. aureus. 3-Hydroxy-3-(2-(2,5-dimethylthiophen-3-yl)-
2-oxoethyl)indolin-2-one (1b) was the most active against S. aureus (MIC 0.026 mmol L–1) 
equivalent to the value exerted by imipenem, whereas compounds 1a, 2a, 3b,c and 4b-f 
showed comparable activity (MIC = 0.044–0.057 mmol L–1). The highest activity of 1b 
against S. aureus is consistent with its highest docking score values inside the binding site 
of S. aureus histidine kinase (grid score –36.231 kcal mol–1, electrostatic energy –0.697 kcal 
mol–1, and van der Waals energy –35.534 kcal mol–1). The main contribution to the docking 
grid score is from van der Waals energy that reflects high geometric complementarity 
which is well known essential for the specific binding.
Analysis of the binding mode of compounds 1a,b to 4a-f to a modeled-structure of 
histidine kinase revealed that these compounds had the same orientation in the binding 
site, and the same hydrogen bonding as well as the X-ray ligand ACP. The high activity of 
compounds 1a,b are supposed to be attributed to the free rotation of the isatin scaffold 
around the bond between indole-C3 and methylene group of the oxyethyl substituent. 
This flexibility plays role in binding efficiency with the histidine kinase receptor. The 
higher activity and top-ranked docking score of compound 1b suggest it as a lead com-
pound for further optimization to design and synthesize more potent and selective anti-S. 
aureus compounds.
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